Rhenium SCT
"Rhenium resin delivers optimal results, minimizing effects on healthy tissue and offering a precise, fast, and painless alternative."
DR. LIDIA SANCHO RODRÍGUEZ SPECIALIST. NUCLEAR MEDICINE DEPARTMENT
What is the Rhenium-SCT?
The Rhenium-SCT is a new therapy for non-melanoma skin cancers. Its main distinction and advantage over other treatments lie in its use of low-dose radiation to treat superficial skin cancers, making it less invasive and sparing the surrounding healthy tissue.
The treatment is performed by a nuclear medicine physician after a dermatologist has evaluated the patient to determine eligibility for the therapy based on a biopsy or ultrasound of the lesion.
The Skin Cancer and Melanoma Area of the Cancer Center at the Clínica Universidad de Navarra focuses on delivering the most precise and personalized treatment possible to achieve the best response with minimal toxicity.
A PERSONALIZED MEDICINE
Second Opinion,
peace of mind
Request a second opinion from our professionals with great experience in the diagnosis and treatment of oncological diseases
In 3 days, without leaving home.
When is treatment with Rhenium-SCT indicated?
The treatment with Rhenium is indicated for non-melanoma skin tumors located in areas of the body with complex geometry or when the skin surface is not flat, such as the face. It is particularly useful in regions like the nose, neck, ears, forehead, lips, and scalp, thanks to its superior aesthetic outcome.
Have you been diagnosed with non-melanoma skin cancer?
Our specialists will assess whether you could benefit from treatment with Rhenium-SCT
How is the Rhenium-SCT treatment performed?
The Rhenium-SCT treatment based on rhenium resin, a chemical element whose radioisotope, rhenium-188, emits beta radiation. In a single session, it targets cancer cells, with a healing process that progresses in stages over 60 to 180 days.
The therapy works within a maximum range of three millimeters, without penetrating the deeper layers of the skin.
The radioactivity is applied exclusively to the lesion through a radioactive paste placed on the affected area for 45 to 180 minutes, depending on the tumor's nature and the rhenium-188 radiation activity. This process is completely painless, outpatient, and poses no risk to the patient or others, as there is no contamination from radioactivity.
During the healing process, patients may experience redness, crusting, itching, or even mild bleeding during the initial phase of recovery, before the body starts eliminating dead cancer cells and replacing them with new cells. Once the process is complete, no scars or deformities remain.
Where do we do it?
IN NAVARRA AND MADRID
The Department of Dermatology
of the Clínica Universidad de Navarra
The Department of Dermatology of the Clinica Universidad de Navarra has extensive experience in the diagnosis and treatment of dermatological diseases.
We have extensive experience in highly precise surgical treatments, such as Mohs surgery. This procedure requires highly specialized personnel.
We have the latest technology for the dermo-aesthetic treatment of skin lesions, with the aim of achieving the best results for our patients.
Diseases we treat
Why at the Clinica?
- Experts in Mohs Surgery for the treatment of skin cancer.
- We have the best technology for dermo-aesthetic treatments.
- Safety and quality assurance of the best private hospital in Spain.
Our team of professionals
